All Videos Channels
  1. Dr. Fatima Stamford, the Head of Obesity Research at Harvard is Paid Off by Novo Nordisk

    Dr. Fatima Stamford, the Head of Obesity Research at Harvard is Paid Off by Novo Nordisk

    103
    0
    5.48K
    9
  3. Earnings Exchange: Supermicro, Novo Nordisk, CVS Health

    Earnings Exchange: Supermicro, Novo Nordisk, CVS Health

    48
  4. Novo Nordisk wzywa nas do usunięcia filmów, pod groźbą kary!! Zaczęło się!

    Novo Nordisk wzywa nas do usunięcia filmów, pod groźbą kary!! Zaczęło się!

    78
    0
    2.5K
    3
  5. Novo Nordisk is scaling Wegovy supply 'significantly': CFO

    Novo Nordisk is scaling Wegovy supply 'significantly': CFO

  6. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    20
  7. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    20
  8. Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says

    Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says

    20
  9. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    26
  10. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    22
  11. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    20
  12. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    25
  13. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    23
  14. Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says

    Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says

    16
  15. Novo Nordisk CEO defends high price off Ozempic and Wegovy

    Novo Nordisk CEO defends high price off Ozempic and Wegovy

    11
  16. Novo Nordisk CEO defends high price off Ozempic and Wegovy

    Novo Nordisk CEO defends high price off Ozempic and Wegovy

    4
  17. Novo Nordisk CEO on Wegovy, Ozempic, Profit Forecast, US Market

    Novo Nordisk CEO on Wegovy, Ozempic, Profit Forecast, US Market

    28
  18. Novo Nordisk CEO defends high price off Ozempic and Wegovy

    Novo Nordisk CEO defends high price off Ozempic and Wegovy

    9
Prev Next